Key takeaways:
Many oral medications are available to treat Crohn’s disease. This includes aminosalicylates like sulfasalazine, corticosteroids like budesonide, and immunomodulators like azathioprine.
The best treatment for Crohn’s disease depends how much inflammation you have and what part of your gastrointestinal tract is affected. Your treatment plan will also depend on affordability, expected side effects, and which medications have worked for you in the past.
There are ways to save on Crohn’s disease medications. Many options are available as lower-cost generics or have copay savings opportunities. GoodRx can help make your prescription more affordable.
If you find yourself having worsening symptoms of Crohn’s disease, you may be experiencing a flare-up. Thankfully, many Crohn’s disease medications are available to help you feel better and achieve remission. Some are oral pills, while others are biologics that are injected or infused into your body. And sometimes, a combination of medications might be needed.
Oral medications are convenient to use when possible. Aminosalicylates, corticosteroids (steroids), and immunomodulators are all common choices to manage this inflammatory health condition. Antibiotics, over-the-counter (OTC) medicines, and newer medications like Rinvoq (upadacitinib) can also make a difference when called upon.
The best choice for treating Crohn’s disease depends on many factors. The part of your gastrointestinal (GI) tract that’s affected and your severity of inflammation are important considerations. Let’s take a look at eight oral Crohn’s disease medications and when healthcare providers may prescribe them.
Keep in mind: Crohn’s disease commonly affects children. Some people have Crohn’s while pregnant or nursing, too. Your healthcare provider can help find treatments safest for these situations. The medications discussed here focus on general usage in adults.
Budesonide (Entocort EC, Ortikos) is a steroid used to treat flare-ups from Crohn’s disease. You may take once-daily budesonide if you have Crohn’s disease in a specific area of the intestines. Entocort EC is available as 3 mg capsules, while Ortikos is available as 6 mg and 9 mg capsules.
This medication is fast-acting. So you may notice a difference in your symptoms within days of starting the medication. Steroids can provide short-term relief, but experts generally don’t recommend taking them for longer than 2 to 4 months at a time. This is mostly because of their potential side effects. However, budesonide has fewer side effects than many other steroids.
Good to know: The specific versions of budesonide that treat Crohn’s disease have a delayed-release mechanism. They need to stay intact to work as intended; so don’t open, crush, or chew the capsules.
Budesonide isn’t the only steroid for Crohn’s disease. Other steroids can reduce inflammation and induce remission of active Crohn’s disease, too. In fact, steroids, such as prednisone and methylprednisolone (Medrol), work better when your GI inflammation isn’t limited to one specific area. Your symptoms may start to improve within days of starting one of these oral steroids.
Again, steroids should only be used for the short-term management of Crohn’s disease. This is because they have many side effects that can affect your health and quality of life. Some of the potential long-term side effects of steroids include:
Weight gain
Weaker bones
Higher risk for infections
High blood pressure
High blood glucose (sugar)
Mood and sleep problems
Cataracts and glaucoma
Sulfasalazine (Azulfidine), mesalamine (Lialda, Apriso, others), and olsalazine (Dipentum) are aminosalicylate medications. They’re used to improve inflammation (swelling) in mild to moderate Crohn’s disease — especially if you only have inflammation in the colon.
Sulfasalazine is available as a 500 mg tablet. The usual dose is 1 tablet 4 times a day. Olsalazine is available as a 250 mg capsule, with a recommended dosage of 2 tablets twice daily. Mesalamine comes as several different brand names, with dosing varying per medication.
As with all medications, some side effects are possible. Sulfasalazine often leads to appetite loss, upset stomach, and headache. It can also stir up trouble if you have a sulfa allergy. Mesalamine can cause watery diarrhea, skin rashes, and problems with your blood or kidneys — but these aren’t common. Stomach cramps and diarrhea commonly occur with olsalazine.
Good to know: These medications are used off-label for Crohn’s disease — meaning the FDA has not approved them for this use. They’re more effective for ulcerative colitis, but sometimes they’re also used for Crohn’s.
Azathioprine (Azasan, Imuran) and mercaptopurine (Purinethol, Purixan) are immunomodulators used off-label for moderate to severe Crohn’s disease, often in combination with a biologic medication. They help with swelling and irritation in your digestive tract by lowering your immune response.
Unlike steroids, these treatments don’t start working right away. It can take up to 3 months to notice an improvement in symptoms after starting an immunomodulator. They’re often given with a faster-acting medicine, such as a steroid.
Azathioprine is available as a 50 mg tablet, but lower doses are sometimes used. Mercaptopurine is also available as a 50 mg tablet. Azathioprine and mercaptopurine are sometimes referred to as “steroid-sparing” medications because they can also help decrease the need for the long-term use of steroids. They can also help you stay in remission.
Common side effects of azathioprine and mercaptopurine include diarrhea, nausea, and tiredness. But more serious effects are possible, especially with higher doses. Your healthcare provider will prescribe the lowest dose possible. Severe side effects include liver problems, low blood counts, and cancer (though this is rare).
Medications like methotrexate (Trexall, others) that reduce the activity of your immune system are commonly used for autoimmune conditions.
However, oral methotrexate isn’t a common treatment for Crohn’s disease. Most studies show it’s not very effective. Injectable methotrexate forms are more commonly used for Crohn’s, usually in combination with another medication. Mouth sores, liver problems, and lung problems can all pose an issue when taking methotrexate.
Rinvoq (upadacitinib) is the first FDA-approved oral treatment for moderately to severely active Crohn’s disease. This Janus kinase (JAK) inhibitor works by blocking JAK enzymes (proteins) that contribute to inflammation.
This oral tablet may be an option for you if you haven’t had a good response to TNF blocker medications. Humira (adalimumab), an injectable biologic medication, is one popular TNF blocker.
The recommended initial Rinvoq dosage in adults is 45 mg once daily for 12 weeks (3 months). After 12 weeks, you usually drop down to a maintenance dosage of 15 mg once daily. But some people may need 30 mg once daily to manage their Crohn’s.
Some of the most common Rinvoq side effects are acne, fever, and anemia. Common colds and headaches also bother some people. In some cases, Rinvoq has been linked to more serious health issues. It has boxed warnings, the FDA’s most serious type of warning, for serious infections and cancer. This is also the case for heart-related health issues such as heart attack, stroke, and blood clots.
Antibiotics such as metronidazole (Flagyl) and ciprofloxacin (Cipro) can treat complications of Crohn’s disease, such as fistulas and abscesses. An abscess is a painful, inflamed, pus-filled area caused by infection. A fistula is an abnormal pathway between two organs or between an organ and the outside of the body. Metronidazole can also help prevent the recurrence of Crohn’s disease after surgery.
However, oral antibiotics such as these aren’t a routine treatment. They’re typically only used when these situations pop up.
In some cases, OTC medications can help relieve symptoms of Crohn’s disease. They’re taken on an as-needed basis — not a routine basis. This includes pain relievers such as Tylenol (acetaminophen), anti-diarrhea drugs such as Imodium A-D (loperamide), and anti-gas treatments such as Gas-X (simethicone).
These aren’t the only OTC options at your disposal. Be sure to talk to your healthcare provider about OTC medications you can take. They can tell you which medications are appropriate to try. And reach back out again if your symptoms worsen or don’t get better in a few days.
There’s no one best Crohn’s disease medication. The best treatment(s) for you depends on many factors, including:
The location and severity of your GI inflammation
How your symptoms are affecting your day-to-day life
How you responded to Crohn’s medications in the past
Your risk for medication side effects
Whether you have a fistula or other intestinal changes
What options are affordable or covered by your insurance
You and your healthcare provider can work together to find a Crohn’s disease medication that’s right for you. Keep in mind that it sometimes takes some trial-and-error to find the most helpful treatment.
There are ways to save on your Crohn’s disease medication(s). GoodRx can help you navigate your options, which may include GoodRx discounts, copay savings cards, and patient assistance programs. You can find Crohn’s disease medication prices as low as $12 with a free GoodRx discount.
A range of oral Crohn’s disease medications are available, each with their own benefits and risks. If you’re having a flare-up in your colon, your healthcare provider may prescribe a medication like sulfasalazine. If it is in another area, you may be given a steroid like budesonide. And if a TNF blocker hasn’t worked well for you in the past, you may receive a drug like Rinvoq instead. Your healthcare provider can determine the best treatment plan for you.
AbbVie Inc. (2023). Rinvoq- upadacitinib tablet, extended release [package insert].
American Health Packaging. (2023). Azathioprine- azathioprine tablet [package insert].
Centers for Disease Control and Prevention. (2020). Skin infections.
Choi, J., et al. (2022). Sulfasalazine. StatPearls.
Crohn’s and Colitis Foundation. (n.d.). Corticosteroids.
Crohn’s and Colitis Foundation. (2023). Mesalamine - oral.
Ferring Pharmaceuticals Inc. (2023). Ortikos- budesonide capsule [package insert].
Feuerstein, J. D., et al. (2021). AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing crohn’s disease. Gastroenterology.
Gade, A. K., et al. (2020). Medical management of crohn's disease. Cureus.
Golden State Medical Supply, Inc. (2023). Budesonide (enteric coated)- budesonide capsule, delayed release pellets [package insert].
Lichtenstein, G. R., et al. (2018). ACG clinical guideline: Management of crohn's disease in adults. American Journal of Gastroenterology.
Meda Pharmaceuticals Inc. (2022). Dipentum- olsalazine sodium capsule, gelatin coated [package insert].
MedlinePlus. (2016). Fistulas.
Mohammadi, O., et al. (2023). Azathioprine. StatPearls.
Mylan Pharmaceuticals Inc. (2022). Mercaptopurine- mercaptopurine tablet [package insert].
Nakashima, J., et al. (2023). Mesalamine (USAN). StatPearls.
National Institute of Diabetes and Digestive and Kidney Diseases. (2017). Treatment for crohn’s disease.
RemedyRepack Inc. (2023). Sulfasalazine- sulfasalazine tablet [package insert].
Shah, R. S., et al. (2021). Medical therapies for postoperative Crohn’s disease. Therapeutic Advances in Gastroenterology.
U.S. Food and Drug Administration. (2023). FDA approves first oral treatment for moderately to severely active Crohn’s disease.